Related Experiment Video

Updated: Sep 21, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Treatment of chronic hepatitis C virus infection in children

M H Chang1

  • 1Department of Pediatrics, College of Medicine, National Taiwan University, Taipei.

Bailliere'S Best Practice & Research. Clinical Gastroenterology
|July 13, 2000
PubMed

Insights

Hepatitis C virus (HCV) infection in children can resolve spontaneously or become chronic. Interferon therapy shows variable response rates, with sustained benefits in over half of treated pediatric patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is less common in children than adults, with transmission via mother-to-infant, blood products, or unsterile needles.
  • While some children experience acute infection and spontaneous resolution, 60-80% develop chronic HCV, posing long-term risks of liver cirrhosis and hepatoma.

Purpose of the Study:

  • To review the epidemiology, natural course, and treatment of Hepatitis C virus infection in pediatric populations.
  • To evaluate the efficacy and response rates of interferon-based therapies in children with chronic HCV infection.

Main Methods:

  • Review of existing literature on pediatric HCV infection.
  • Analysis of treatment outcomes, including response rates and sustained virologic response to interferon therapy in children.
  • Discussion of recommended treatment durations and response evaluation timing.

Main Results:

  • HCV infection in children can be acute and resolving (20-40%) or chronic (60-80%) with mild fibrosis.
  • Interferon therapy response rates range from 25-90%, with sustained responses in 36-56% of children 6-36 months post-therapy.
  • Recommended therapy duration is 12 months, with response evaluation at 3 months (or 6 months for thalassemia patients).

Conclusions:

  • Chronic Hepatitis C virus infection in children requires careful management due to long-term risks.
  • Interferon is a primary treatment, demonstrating variable but significant sustained response rates in pediatric patients.
  • Further research into combination therapies like interferon and ribavirin is ongoing for pediatric HCV.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...